Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
National Advertising Division
Content Hub
Eli Lilly wins argument over Noom’s GLP-1 dosing claims
Lilly challenged Noom’s “A Smaller Dose. A Smarter Start” claim, leading the NAD to recommend the digital health company change or drop the statement.
Nick Paul Taylor
May 27, 2026 2:09am
Semaglutide compounder drops claims after Novo Nordisk challenge
Nov 21, 2025 9:20am
Pfizer's challenge of BridgeBio ads referred to federal agencies
Nov 10, 2025 11:15am
Galderma's itch relief claims scratched after Sanofi complaint
Oct 8, 2025 9:45am
Maze, Vertex marketing spat escalates to federal regulators
Aug 28, 2025 10:49am
Exact's Genomic Health puts Agendia in ad watchdog's crosshairs
Aug 13, 2025 12:23pm
